Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 1,034,500 | 975,000 | 871,300 | 741,500 | 815,200 |
| Cost of Goods | 377,900 | 351,700 | 324,900 | 278,900 | 273,900 |
| Gross Profit | 656,600 | 623,300 | 546,400 | 462,600 | 541,300 |
| Operating Expenses | 440,600 | 418,500 | 419,200 | 416,300 | 416,800 |
| Operating Income | 216,900 | 205,500 | 128,100 | 47,200 | 125,400 |
| Other Income | 29,300 | 34,900 | 31,200 | 17,300 | 7,800 |
| Pre-tax Income | 246,200 | 240,400 | 159,300 | 64,500 | 133,200 |
| Income Tax | -10,100 | 119,700 | 43,400 | 15,900 | 41,400 |
| Net Income Continuous | 256,300 | 120,700 | 115,900 | 48,600 | 91,800 |
| Net Income | $256,300 | $120,700 | $115,900 | $48,600 | $91,800 |
| EPS Basic Total Ops | 0.66 | 0.31 | 0.30 | 0.13 | 0.24 |
| EPS Basic Continuous Ops | 0.67 | 0.31 | 0.30 | 0.13 | 0.24 |
| EPS Diluted Total Ops | 0.61 | 0.29 | 0.28 | 0.12 | 0.23 |
| EPS Diluted Continuous Ops | 0.61 | 0.28 | 0.27 | 0.12 | 0.21 |
| EBITDA(a) | $269,400 | $253,700 | $171,800 | $88,800 | $161,700 |